Physician profile
Fabio Settecase
NPI 1942453618
$757,618.52
in general payments reported to CMS, 2019-2025
9 companies · $347K in 2025
The $347K reported for 2025 was more than what 99% of Neuroradiology providers received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $241 · 2021: $8,868 · 2022: $24K · 2023: $112K · 2024: $265K · 2025: $347K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $721K · Food and Beverage: $3,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $720,841.56 |
| Food and Beverage | $3,441.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Route 92 Medical, INC. | $740,032.45 | 2022-2025 | 8f Base Camp Sheath System |
| Stryker Corporation | $15,489.19 | 2020-2025 | Surpass Evolve, Excelsior Sl-10, Axs Vecta 71 |
| Medtronic, INC. | $999.31 | 2021-2022 | |
| Atricure, INC. | $419.96 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Microvention, INC. | $330.07 | 2021-2025 | Web Aneurysm Embolization System, Headway Advanced Soft |
| Rapid Medical Ltd | $153.82 | 2025 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Balt USA, LLC | $135.03 | 2020 | |
| Depuy Synthes Sales INC. | $30.74 | 2021 | |
| Penumbra, INC. | $27.95 | 2024 | Red 72 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,098,555.54 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabio Settecase listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.